Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing

This work reports the first electrochemical bioplatform developed for the determination of human endostatin (HE), a biomarker with recognized antiangiogenic potential whose elevated circulating levels have also been associated with the development of aggressive cancers. The developed electroanalytic...

Descripción completa

Detalles Bibliográficos
Autores: Tejerina Miranda, Sandra, Pedrero Muñoz, María, Blázquez García, Marina, Serafín González-Carrato, Verónica, Montero Calle, Ana, Garranzo Asensio, María, Reviejo García, Ángel Julio, Pingarrón Carrazón, José Manuel, Barderas Manchado, Rodrigo, Campuzano Ruiz, Susana
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/105630
Acceso en línea:https://hdl.handle.net/20.500.14352/105630
Access Level:acceso abierto
Palabra clave:543
Electrochemical bioplatform
Endostatin
Angiogenesis
Colorectal cancer aggressiveness
Tissue
Plasma
Ciencias
2301 Química Analítica
id ES_7d8b34a2984c19d7907c48d23c4911d7
oai_identifier_str oai:docta.ucm.es:20.500.14352/105630
network_acronym_str ES
network_name_str España
repository_id_str
spelling Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensingTejerina Miranda, SandraPedrero Muñoz, MaríaBlázquez García, MarinaSerafín González-Carrato, VerónicaMontero Calle, AnaGarranzo Asensio, MaríaReviejo García, Ángel JulioPingarrón Carrazón, José ManuelBarderas Manchado, RodrigoCampuzano Ruiz, Susana543Electrochemical bioplatformEndostatinAngiogenesisColorectal cancer aggressivenessTissuePlasmaCiencias2301 Química AnalíticaThis work reports the first electrochemical bioplatform developed for the determination of human endostatin (HE), a biomarker with recognized antiangiogenic potential whose elevated circulating levels have also been associated with the development of aggressive cancers. The developed electroanalytical biotool combines the benefits of using magnetic microparticles for the implementation of sandwich immunoassays and amperometric transduction on disposable carbon electrodes. A limit of detection (LOD) of 34.1 pg mL−1 for HE standards and a selectivity suitable for its foray into the clinical oncology area, are demonstrated. The determination of HE in clinical samples such as lysates and secretomes of colorectal cancer (CRC) cells, plasma, and tissue samples from patients with CRC in different stages, has been faced with satisfactory results showing the ability for discriminating the metastatic capabilities of cells and for identifying and staging CRC patients. The developed bioplatform allows precise quantitative determinations, requiring minimal pre-treatments and sample amounts in only 75 min. In addition, due to the instrumentation and the type of substrates used in the detection step, the biotool is compatible with implementation in multiplexed and/or point-of-need devices, features in which this bioplatform is advantageous with respect to the enzyme linked immunosorbent assay (ELISA) or immunoblotting technologies.ElsevierUniversidad Complutense de Madrid20242024-01-0120242024-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/105630reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/1056302026-06-02T12:44:21Z
dc.title.none.fl_str_mv Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
title Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
spellingShingle Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
Tejerina Miranda, Sandra
543
Electrochemical bioplatform
Endostatin
Angiogenesis
Colorectal cancer aggressiveness
Tissue
Plasma
Ciencias
2301 Química Analítica
title_short Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
title_full Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
title_fullStr Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
title_full_unstemmed Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
title_sort Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
dc.creator.none.fl_str_mv Tejerina Miranda, Sandra
Pedrero Muñoz, María
Blázquez García, Marina
Serafín González-Carrato, Verónica
Montero Calle, Ana
Garranzo Asensio, María
Reviejo García, Ángel Julio
Pingarrón Carrazón, José Manuel
Barderas Manchado, Rodrigo
Campuzano Ruiz, Susana
author Tejerina Miranda, Sandra
author_facet Tejerina Miranda, Sandra
Pedrero Muñoz, María
Blázquez García, Marina
Serafín González-Carrato, Verónica
Montero Calle, Ana
Garranzo Asensio, María
Reviejo García, Ángel Julio
Pingarrón Carrazón, José Manuel
Barderas Manchado, Rodrigo
Campuzano Ruiz, Susana
author_role author
author2 Pedrero Muñoz, María
Blázquez García, Marina
Serafín González-Carrato, Verónica
Montero Calle, Ana
Garranzo Asensio, María
Reviejo García, Ángel Julio
Pingarrón Carrazón, José Manuel
Barderas Manchado, Rodrigo
Campuzano Ruiz, Susana
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidad Complutense de Madrid
dc.subject.none.fl_str_mv 543
Electrochemical bioplatform
Endostatin
Angiogenesis
Colorectal cancer aggressiveness
Tissue
Plasma
Ciencias
2301 Química Analítica
topic 543
Electrochemical bioplatform
Endostatin
Angiogenesis
Colorectal cancer aggressiveness
Tissue
Plasma
Ciencias
2301 Química Analítica
description This work reports the first electrochemical bioplatform developed for the determination of human endostatin (HE), a biomarker with recognized antiangiogenic potential whose elevated circulating levels have also been associated with the development of aggressive cancers. The developed electroanalytical biotool combines the benefits of using magnetic microparticles for the implementation of sandwich immunoassays and amperometric transduction on disposable carbon electrodes. A limit of detection (LOD) of 34.1 pg mL−1 for HE standards and a selectivity suitable for its foray into the clinical oncology area, are demonstrated. The determination of HE in clinical samples such as lysates and secretomes of colorectal cancer (CRC) cells, plasma, and tissue samples from patients with CRC in different stages, has been faced with satisfactory results showing the ability for discriminating the metastatic capabilities of cells and for identifying and staging CRC patients. The developed bioplatform allows precise quantitative determinations, requiring minimal pre-treatments and sample amounts in only 75 min. In addition, due to the instrumentation and the type of substrates used in the detection step, the biotool is compatible with implementation in multiplexed and/or point-of-need devices, features in which this bioplatform is advantageous with respect to the enzyme linked immunosorbent assay (ELISA) or immunoblotting technologies.
publishDate 2024
dc.date.none.fl_str_mv 2024
2024-01-01
2024
2024-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.14352/105630
url https://hdl.handle.net/20.500.14352/105630
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Docta Complutense
instname:Universidad Complutense de Madrid (UCM)
instname_str Universidad Complutense de Madrid (UCM)
reponame_str Docta Complutense
collection Docta Complutense
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411671917723648
score 15,811543